Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel Adductor Canal Block vs Femoral Nerve Catheter for ACL Reconstruction
NCT05161221Phase 3Unknown
- Sponsor
- Rothman Orthopaedics
- Start
- Dec 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of liposomal bupivacaine in postoperative pain (2 arms), sponsored by Rothman Orthopaedics. Primary endpoints: Patient satisfaction at 8 weeks and Post operative pain management at 8 weeks. Status: unknown.
02
Drugs
liposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05161221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05161221.